|
Zanganeh Mahkam
|
Co-Chief Executive Officer |
Summit Therapeutics Inc. (SMMT)
|
2023-03-08 |
$1.05 |
1090.5% |
$269,384,654
|
23,527,044
|
$24,703,396 |
|
Koppel Adam
|
Non-Executive Director |
Cerevel Therapeutics Holdings, Inc. (CERE)
|
2023-10-16 |
$22.81 |
97.1% |
$121,383,146
|
5,480,052
|
$124,999,986 |
|
Gordon Christopher R
|
Non-Executive Director |
Cerevel Therapeutics Holdings, Inc. (CERE)
|
2023-10-16 |
$22.81 |
97.1% |
$121,383,146
|
5,480,052
|
$124,999,986 |
|
Duggan Robert W
|
Non-Executive Director |
Pulse Biosciences, Inc. (PLSE)
|
2023-05-09 |
$6.51 |
168.5% |
$109,951,619
|
10,022,937
|
$65,249,320 |
|
Fairmount Funds Management Llc
|
Non-Executive Director |
Apogee Therapeutics, Inc. (APGE)
|
2023-07-13 |
$17.00 |
183.8% |
$91,882,344
|
2,941,176
|
$49,999,992 |
|
Ehrsam Frederick Ernest Iii
|
Non-Executive Director |
Coinbase Global, Inc. (COIN)
|
2023-05-10 |
$61.77 |
158.5% |
$79,321,995
|
810,000
|
$50,035,002 |
|
Sarofim Christopher Binyon
|
Non-Executive Director |
Sable Offshore Corp. (SOC)
|
2024-02-14 |
$10.00 |
116.1% |
$69,660,006
|
6,000,000
|
$60,000,000 |
|
Casdin Eli
|
Non-Executive Director |
GeneDx Holdings Corp. (WGS)
|
2023-01-31 |
$11.55 |
182.4% |
$54,727,270
|
2,597,403
|
$30,000,000 |
|
Shah Nimish P
|
Non-Executive Director |
Apogee Therapeutics, Inc. (APGE)
|
2023-07-13 |
$17.00 |
183.8% |
$54,670,004
|
1,750,000
|
$29,750,000 |
|
Enright Patrick G
|
Non-Executive Director |
Vera Therapeutics, Inc. (VERA)
|
2023-02-06 |
$7.00 |
445.1% |
$53,417,121
|
1,714,285
|
$11,999,995 |
|
Ra Capital Management, L.P.
|
Non-Executive Director |
Eliem Therapeutics, Inc. (ELYM)
|
2024-06-27 |
$3.84 |
97.1% |
$48,521,877
|
13,008,546
|
$49,952,817 |
|
Emanuel Ariel
|
Chief Executive Officer |
TKO Group Holdings, Inc. (TKO)
|
2024-04-09 |
$89.01 |
30.5% |
$44,655,928
|
1,642,970
|
$146,240,760 |
|
White Mountains Insurance Group Ltd
|
Non-Executive Director |
MediaAlpha, Inc. (MAX)
|
2023-06-30 |
$10.00 |
72.6% |
$42,956,084
|
5,916,816
|
$59,168,160 |
|
Flores James C
|
Chairman |
Sable Offshore Corp. (SOC)
|
2024-02-14 |
$10.01 |
115.9% |
$37,330,123
|
3,217,500
|
$32,200,055 |
|
Soni Manmeet Singh
|
Chief Operating Officer |
Summit Therapeutics Inc. (SMMT)
|
2023-10-13 |
$1.68 |
644.0% |
$32,202,376
|
2,976,190
|
$4,999,999 |
|
Lichter Jay
|
Non-Executive Director |
Janux Therapeutics, Inc. (JANX)
|
2023-11-13 |
$5.87 |
644.6% |
$32,158,475
|
849,854
|
$4,988,643 |
|
Kersten Dirk
|
Non-Executive Director |
Dyne Therapeutics, Inc. (DYN)
|
2024-01-09 |
$17.50 |
92.3% |
$27,685,706
|
1,714,285
|
$29,999,988 |
|
Rothbaum Wayne P.
|
Non-Executive Director |
IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
|
2023-09-15 |
$5.30 |
97.4% |
$25,800,000
|
5,000,000
|
$26,500,000 |
|
Ra Capital Management, L.P.
|
Non-Executive Director |
ARS Pharmaceuticals, Inc. (SPRY)
|
2023-09-21 |
$3.03 |
287.7% |
$23,541,474
|
2,700,000
|
$8,183,526 |
|
Katabi Maha
|
Non-Executive Director |
RayzeBio, Inc. (RYZB)
|
2023-09-19 |
$18.00 |
247.2% |
$21,009,158
|
472,222
|
$8,499,996 |
|
Ra Capital Management, L.P.
|
Non-Executive Director |
ARS Pharmaceuticals, Inc. (SPRY)
|
2023-08-29 |
$6.20 |
89.5% |
$20,812,500
|
3,750,000
|
$23,250,000 |
|
Tammenoms Bakker Juliet
|
Non-Executive Director |
RxSight, Inc. (RXST)
|
2023-02-10 |
$12.50 |
328.0% |
$19,680,000
|
480,000
|
$6,000,000 |
|
Cui Xiangmin
|
Non-Executive Director |
ALPINE IMMUNE SCIENCES, INC. (ALPN)
|
2023-11-09 |
$12.50 |
419.8% |
$19,676,250
|
375,000
|
$4,687,500 |
|
Perceptive Advisors Llc
|
Non-Executive Director |
Cerevel Therapeutics Holdings, Inc. (CERE)
|
2023-10-16 |
$22.81 |
97.1% |
$19,421,296
|
876,808
|
$19,999,990 |
|
Jagid Jeffrey M
|
Chief Executive Officer |
ATLANTIC INTERNATIONAL CORP. (ATLN)
|
2024-06-18 |
$2.36 |
196.6% |
$17,331,184
|
3,735,169
|
$8,814,999 |
|
Chan Shiu Leung
|
Non-Executive Director |
Super Micro Computer, Inc. (SMCI)
|
2023-08-11 |
$26.56 |
1461.2% |
$15,521,720
|
40,000
|
$1,062,280 |
|
Ra Capital Management, L.P.
|
Non-Executive Director |
Janux Therapeutics, Inc. (JANX)
|
2023-07-19 |
$12.46 |
250.8% |
$15,469,000
|
495,008
|
$6,167,800 |
|
Wallace Rory
|
Non-Executive Director |
Barnes & Noble Education, Inc. (BNED)
|
2024-06-10 |
$5.00 |
147.0% |
$14,882,337
|
2,024,808
|
$10,124,039 |
|
Bvf Partners L P/Il
|
Non-Executive Director |
Kymera Therapeutics, Inc. (KYMR)
|
2023-11-03 |
$12.80 |
264.0% |
$13,995,967
|
414,105
|
$5,301,325 |
|
Schroeder Thilo
|
Non-Executive Director |
Revolution Medicines, Inc. (RVMD)
|
2023-03-10 |
$21.76 |
98.7% |
$13,960,397
|
650,000
|
$14,145,604 |
|
Jana Partners Management, Lp
|
Non-Executive Director |
MERCURY SYSTEMS INC (MRCY)
|
2024-02-09 |
$27.90 |
34.7% |
$12,931,011
|
1,335,848
|
$37,270,159 |
|
Springer Timothy A
|
Non-Executive Director |
Morphic Holding, Inc. (MORF)
|
2023-05-03 |
$45.00 |
26.6% |
$12,589,502
|
1,050,000
|
$47,250,000 |
|
Gupta Ravi
|
Non-Executive Director |
Maplebear Inc. (CART)
|
2024-02-22 |
$28.54 |
21.3% |
$12,286,139
|
2,020,273
|
$57,655,710 |
|
Chan Shiu Leung
|
Non-Executive Director |
Super Micro Computer, Inc. (SMCI)
|
2023-02-03 |
$8.55 |
4750.3% |
$12,181,560
|
30,000
|
$256,440 |
|
Chan Shiu Leung
|
Non-Executive Director |
Super Micro Computer, Inc. (SMCI)
|
2023-05-11 |
$13.39 |
2996.8% |
$12,036,360
|
30,000
|
$401,640 |
|
Levan Jarett
|
CEO and President |
BBX Capital, Inc. (B)
|
2024-02-02 |
$11.08 |
240.0% |
$11,045,352
|
415,395
|
$4,602,577 |
|
Baker Bros. Advisors Lp
|
Non-Executive Director |
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
|
2023-11-14 |
$146.99 |
67.4% |
$10,643,733
|
107,499
|
$15,801,021 |
|
Ra Capital Management, L.P.
|
Non-Executive Director |
DICE Therapeutics, Inc. (DICE)
|
2023-03-27 |
$26.99 |
76.2% |
$10,248,965
|
498,556
|
$13,457,372 |
|
Perceptive Advisors Llc
|
Non-Executive Director |
Solid Biosciences Inc. (SLDB)
|
2024-01-11 |
$5.53 |
53.9% |
$10,163,925
|
3,410,713
|
$18,861,243 |
|
Bartholdson John A.
|
Non-Executive Director |
Bioventus Inc. (BVS)
|
2023-05-22 |
$1.96 |
393.9% |
$10,136,273
|
1,315,673
|
$2,573,128 |
|
Seidenberg Beth C
|
Non-Executive Director |
Vera Therapeutics, Inc. (VERA)
|
2023-02-08 |
$7.10 |
437.2% |
$9,661,148
|
311,078
|
$2,209,588 |
|
Ra Capital Management, L.P.
|
Non-Executive Director |
DICE Therapeutics, Inc. (DICE)
|
2023-03-30 |
$29.07 |
63.6% |
$9,411,151
|
509,145
|
$14,798,693 |
|
Warren Kelcy L
|
Executive Chairman |
Energy Transfer LP (ET)
|
2023-08-21 |
$12.96 |
23.6% |
$9,167,500
|
3,000,000
|
$38,892,500 |
|
Nodelman Oleg
|
Non-Executive Director |
Nuvation Bio Inc. (NUVB)
|
2023-02-21 |
$1.26 |
128.6% |
$8,609,463
|
5,313,100
|
$6,692,265 |
|
Doak Michael
|
Non-Executive Director |
TWFG, Inc. (TWFG)
|
2024-07-19 |
$17.00 |
81.9% |
$8,188,231
|
588,235
|
$9,999,995 |
|
Botha Roelof
|
Non-Executive Director |
Block, Inc. (SQ)
|
2023-11-13 |
$50.89 |
26.9% |
$7,399,801
|
540,646
|
$27,515,119 |
|
Low Check Kian
|
Non-Executive Director |
Broadcom Inc. (AVGO)
|
2023-09-06 |
$87.20 |
75.2% |
$7,217,919
|
110,000
|
$9,592,282 |
|
Chan Shiu Leung
|
Non-Executive Director |
Super Micro Computer, Inc. (SMCI)
|
2024-02-01 |
$56.80 |
629.9% |
$7,156,000
|
20,000
|
$1,136,000 |
|
Coric Vlad
|
Chief Executive Officer |
Biohaven Ltd. (BHVN)
|
2023-10-05 |
$22.00 |
67.8% |
$6,781,810
|
454,545
|
$9,999,990 |
|
Childs John W
|
Non-Executive Director |
Biohaven Ltd. (BHVN)
|
2023-10-05 |
$22.00 |
67.8% |
$6,781,810
|
454,545
|
$9,999,990 |